SCHEMBL16907765

SCHEMBL16907765

COc1ccc(C(=N)c2cc(CC(=O)O)c(-c3ccc(Cl)cc3)s2)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 2/20 0.66
MEN1 O00255 2/20 0.66
KMT2A Q03164 2/20 0.66
PTGDR2 Q9Y5Y4 4/20 0.47
MAPT P10636 4/20 0.46
AKR1C4 P17516 2/20 0.45
PTGS1 P23219 2/20 0.45
AKR1C3 P42330 2/20 0.45
AKR1C2 P52895 2/20 0.45
HPGD P15428 2/20 0.43
OPRD1 P41143 1/20 0.41
PPARD Q03181 1/20 0.41
TP53 P04637 2/20 0.41
ALOX5 P09917 2/20 0.40
ABCB1 P08183 2/20 0.40
KDM4E B2RXH2 1/20 0.40
PTGES O14684 1/20 0.40
ABCC3 O15438 1/20 0.40
ABCC4 O15439 1/20 0.40
ABCB11 O95342 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15545878 0.89 RXFP1 (0.75) RXFP1MEN1KMT2APTGDR2MAPT
SCHEMBL16907763 0.88 MEN1 (0.52) RXFP1MEN1KMT2APTGDR2MAPT
SCHEMBL19413844 0.85 MEN1 (0.64) RXFP1MEN1KMT2APTGDR2MAPT
SCHEMBL15545700 0.85 RXFP1 (0.64) RXFP1MEN1KMT2APTGDR2MAPT
SCHEMBL15546807 0.84 MEN1 (0.63) RXFP1MEN1KMT2APTGDR2MAPT
SCHEMBL16907843 0.83 RXFP1 (0.50) RXFP1MEN1KMT2APTGDR2MAPT
SCHEMBL16907796 0.83 MEN1 (0.47) RXFP1MEN1KMT2AMAPTOPRD1
SCHEMBL15545703 0.83 RXFP1 (0.69) RXFP1MEN1KMT2APTGDR2MAPT
SCHEMBL15545765 0.83 MEN1 (0.61) RXFP1MEN1KMT2APTGDR2MAPT
SCHEMBL18035681 0.83 MEN1 (0.61) RXFP1MEN1KMT2APTGDR2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9777015-B2 Useful thiophene derivatives in the treatment of diabetes METABRAIN RESEARCH (FR) 2017-10-03 US disclosed
EP-2875010-B1 THIOPHENE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES METABRAIN RES (FR) 2016-08-31 EP disclosed
US-20150197530-A1 USEFUL THIOPHENE DERIVATIVES IN THE TREATMENT OF DIABETES METABRAIN RESEARCH (FR) 2015-07-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150197530-A1 USEFUL THIOPHENE DERIVATIVES IN THE TREATMENT OF DIABETES SLC5A2, SLC5A1, TPMT RXFP1 3837/4885MEN1 4184/4885KMT2A 4602/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.